About
We solve real-world problems enormously by helping patients take their medications properly
Every day, millions of people fail to take their medication as determined and the resulting personal and financial costs are staggering. Worldwide, non-compliance generates $ 700 billion in medical costs that can be avoided.
The data we create are unique and have tremendous value for pharmaceutical companies, researchers, and governments.
Whenever a patient uses our CuraServe technology, our data grows in utility and value.
Curaizon ™ solves the problem of drug disobedience by spreading our technology through national health services. As part of our solution, we collect full anonymous data about how and when patients take medication.
CuraTokens ™ is the only way to access our data. Tokens can be exchanged for data access, which will advance medical research, lower health care costs and save lives.
The value of CuraToken ™ is based on real solutions to real problems.
What does the company do?
We aim to improve drug adherence and bring benefits that change the game for patients and healthcare providers by becoming the leading supplier of compliance and data solutions worldwide.
What's unique about the company?
Our solutions work with patients, their families, and health care providers to ensure that patients take their medication as prescribed through a series of outreach tools, supported by predictive modeling tools and behavioral analysis, to improve drug adherence levels.
What problem does the company solve?
Our CuraServe technology helps ensure that patients take their medication as prescribed by their doctor. By doing this, we help patients live longer and healthier lives. We also reduce the cost of health care that occurs when patients fail to take their medication properly.
How do you create value to support your CuraTokens?
Our CuraServe ™ technology generates a large amount of unique and real-time data that shows how people use their most valuable medicines for various groups including pharmaceutical companies, medical researchers, and biotech companies. CuraTokens ™ allows the token owner to access data to create queries. When our solution was launched to more patients in more countries. The more data we generate, the more valuable that CuraTokens ™ becomes.
Who is your target customer?
Curaizon ™ sells its compliance solutions (CuraServe ™) to national health services worldwide. Our end users are health care patients who take any form of medication. We also work with industry academia, pharmacy and biotechnology, as well as other data users through our CuraData ™ solution.
What is your geographic target market?
Curaizon targets countries with national health services. It currently includes 1.4 billion people and that number continues to grow.
What is the market potential?
The global cost of noncompliance is over € 600 billion annually and generates hundreds of thousands of lives lost prematurely. Adherence to chronic and long-term diseases is less than 50%.
CuraToken ™ Utility Tokens (CTKN) allows token holders to access our exclusive and anonymous medical data in blockchain.
CuraTokens ™ is the only way to access Curaizon ™ technology.
CuraToken ™ holders can access data that uses strong analytics, predictions, AIs and large data in the fight against drug non-compliance.
CuraTokens ™ provides real-time analysis of patient behavior and compliance.
CuraTokens ™ allows the use of blockchain technology to manage authentication, confidentiality and accountability by allowing individuals to control their data, providing protection, security, and compliance with all required regulations, including GDPR.
CuraTokens ™ facilitates partnerships with medical and pharmaceutical organizations through a token reward system.
The holders of CuraToken ™ know that they save lives around the world by helping solve the problem of drug non-compliance.
Roadmap
January 2016
Development of CuraServe ™ Starts
June 2017
The CuraServe ™ Testing takes place
February 2018
Rilis Full Alpha CuraData ™
June 1, 2018
Start Token Presale
June 8, 2018
Token Public Sale Begins
November 2018
Full CuraData ™ Beta Release
March 2019
CuraServe ™ Public Release
July 2019
CuraData ™ Platform Growth
2020
Release Curadata ™ 2.0
LEADERSHIP
BUSINESS DEVELOPMENT
TECHNOLOGY
IcoBox
ICO Campaign Partners
ICOBox is the first and largest new generation of Blockchain Growth Promoters and Business Facilitators for companies that want to sell their products through ICO crowdsales.
Gateway Technolabs
Software development
A global information technology services, solutions and product engineering company with a team of brilliant and dedicated professionals serving our customers across 30 countries in 5 continents.
Innohead
Big Data & Predictive Analytics
A Big Data and Predictive Analytics company focused on data mining and customer analytics.
Timengo
IoT, Cloud and security experts
Timengo are IoT, Cloud and security experts with a wealth of knowledge and experience within the healthcare sector. They drive our internal and external technology applications and help us to deliver secure API infrastructure with external databases.
CLX
Tier-1 CPaaS provider
CLX are the only tier-1 CPaaS provider trusted to to carry over 25 billion transactions per year and are our notification partner.
ADVISORS
For more information link below:
Website: https://curatoken.curaizon.com/
Telegram: https://t.me/joinchat/ILiK_Q7VBLOByz_7mMUgsQ
Ann Thread: https://bitcointalk.org/index.php?topic=4401662.0
Twitter: https://twitter.com/curaizon
Author: luioanh
Profile: https://bitcointalk.org/index.php?action=profile;u=1233872